Ex vivo expansion and in vivo infusion of bone marrow-derived Flk-1 +CD31-CD34- mesenchymal stem cells: Feasibility and safety from monkey to human

Stem Cells and Development

Volumn 15, Issue 3, 2006, Pages 349-357

  Liu, Lihui ^b,c   Sun, Zhao ^a,c   Chen, Bin ^a   Han, Qin ^a   Liao, Lianmin ^a   Jia, Mingyue ^a   Cao, Ying ^a   Ma, Jie ^a   Sun, Qiyun ^b   Guo, Mei ^b   Liu, Zeyuan ^b   Ai, Huisheng ^b   Zhao, Robert Chunhua ^a,c  

^a Center of Excellence in Tissue Engineering   (China)

^b BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^c PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; CD34 ANTIGEN; VASCULOTROPIN RECEPTOR 2;

ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ANIMAL CELL; ARTICLE; BLOOD ANALYSIS; BONE MARROW; CELL ISOLATION; CELL PROLIFERATION; CELL SUBPOPULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIPLOIDY; FEASIBILITY STUDY; FEMALE; GENE SEQUENCE; HUMAN; HUMAN CELL; IMMUNOMODULATION; KARYOTYPE; KIDNEY FUNCTION; LABORATORY TEST; LIVER FUNCTION; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MULTIPOTENT STEM CELL; NONHUMAN; NORMAL HUMAN; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; RECIPIENT; RHESUS MONKEY; SAFETY; SRY GENE; TISSUE ENGINEERING;

ADULT; ANIMALS; ANTIGENS, CD31; ANTIGENS, CD34; ANTIGENS, SURFACE; BONE MARROW CELLS; CELL PROLIFERATION; CELLS, CULTURED; CHIMERISM; CHROMOSOMES, MAMMALIAN; FEASIBILITY STUDIES; FEMALE; HAPLORHINI; HUMANS; INFUSIONS, INTRAVENOUS; KARYOTYPING; KIDNEY FUNCTION TESTS; LIVER FUNCTION TESTS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; TRANSPLANTATION, AUTOLOGOUS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

MACACA MULATTA;

EID: 33746265260     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2006.15.349     Document Type: Article

References (28)

1. Friedenstein A, U Gorskaja and N Kalugina. (1976). In vitro growth of bone marrow aspirate derived cell colonies. Exp Hematol 4:267-274.
2. Jiang Y, BN Jahagirdar, RL Reinhardt, RE Schwartz, CD Keene, X Ortiz-Gonzalez R, M Reyes, T Lenvik, T Lund, M Blackstad, J Du, S Aldrich, A Lisberg, WC Low, DA Largaespada and CM Verfaillie. (2002). Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418:414-419.
3. Hu Y, L Liao, Q Wang, L Ma, G Ma, X Jiang and RC Zhao. (2003). Isolation and identification of mesenchymal stem cells from human fetal pancreas. J Lab Clin Med 141:342-349.
4. Conget PA and JJ Minguell. (1999). Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells. J Cell Physiol 181:67-73.
5. Pittenger MF, AM Mackay, SC Beck, RK Jaiswal, R Douglas, JD Mosca, MA Moorman, DW Simonetti, S Craig and DR Marshak. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147.
6. Bartholomew A, C Sturgeon, M Siatskas, K Ferrer, K McIntosh, S Patil, W Hardy, S Devine, D Ucker, R Deans, A Moseley and R Hoffman. (2002). Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 30:42-48.
7. Krampera M, S Glennie, J Dyson, D Scott, R Laylor, E Simpson and F Dazzi. (2003). Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 101:3722-3729.
8. Beyth S, Z Borovsky, D Mevorach, M Liebergall, Z Gazit, H Aslan, E Galun and J Rachmilewitz. (2005). Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood 105:2214-2219.
9. Aggarwal S and MF Pittenger. (2005). Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105:1815-1822.
10. Fang B, M Shi, L Liao, S Yang, Y Liu and RC Zhao. (2004). Systemic infusion of FLK1(+) mesenchymal stem cells ameliorate carbon tetrachloride-induced liver fibrosis in mice. Transplantation 78:83-88.
11. Fang B, L Liao, M Shi, S Yang and RC Zhao. (2004). Multipotency of Flk1CD34 progenitors derived from human fetal bone marrow. J Lab Clin Med 143:230-240.
12. - progenitors. J Hematoether Stem Cell Res 12:603-613.
13. Guo H, B Fang, L Liao, Z Zhao, J Liu, H Chen, SH Hsu, Q Cui and RC Zhao. (2003). Hemangioblastic characteristics of fetal bone marrow-derived Flk1(+)CD31(-) CD34(-) cells. Exp Hematol 31:650-658.
14. Zhang W, W Ge, C Li, S You, L Liao, Q Han, W Deng and RC Zhao. (2004). Effects of mesenchymal stem cells on differentiation, maturation, and function of human monocyte-derived dendritic cells. Stem Cells Dev 13:263-271.
15. Deng W, Q Han, L Liao, C Li, W Ge, Z Zhao, S You, H Deng, F Murad and RC Zhao. (2005). Engrafted bone marrow-derived flk-(1+) mesenchymal stem cells regenerate skin tissue. Tissue Eng 11:110-119.
16. Deng W, Q Han, L Liao, C Li, W Ge, Z Zhao, S You, H Deng and RC Zhao. (2004). Allogeneic bone marrow-derived flk-1+Sca-1- mesenchymal stem cells leads to stable mixed chimerism and donor-specific tolerance. Exp Hematol 32:861-867.
17. Deans RJ and AB Moseley. (2000). Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol 28:875-884.
18. Deans RJ. (2000). Mesenchymal stem cells: cell and gene therapy applications. Eur Cytokine Networks 11:323-324.
19. Bartholomew A, C Sturgeon, M Siatskas, K Ferrer, K McIntosh and S Patil. (2002). Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 30:42-48.
20. Di Nicola M, C Carlo-Stella, M Magni, M Marco, PD Longoni and P Matteucci. (2002). Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99:3838-3843.
21. Lazarus HM, ON Koc, SM Devine, P Curtin, RT Maziarz, HK Holland, EJ Shpall, P McCarthy, K Atkinson, BW Cooper, SL Gerson, MJ Laughlin, FR Loberiza Jr, AB Moseley and A Bacigalupo. (2005). Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant 11:389-398.
22. Le Blanc K, I Rasmusson, B Sundberg, C Gotherstrom, M Hassan, M Uzunel and O Ringden. (2004). Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363:1439-1441.
23. Lazarus HM, SE Haynesworth, SL Gerson, NS Rosenthal and AI Caplan. (1995). Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use. Bone Marrow Transplant 16:557-564.
24. Koc ON, SL Gerson, BW Cooper, SM Dyhouse, SE Haynesworth, AI Caplan and HM Lazarus. (2000). Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol 18:307-316.
25. Lazarus H, P Curtin and S Devine. (2000). Role of mesenchymal stem cells in allogeneic transplantation: early phase I clinical results. Blood 96:392a.
26. MacMillan ML, NKC Ramsay and K Atkinson. (2002). Ex-vivo culture-expanded parental haploidentical mesenchymal stem cells to promote engraftment in recipients of unrelated donor umbilical cord blood: result of a phase I-II clinical trial. Blood 100:836a.
27. Rubio D, J Garcia-Castro, MC Martin, R de la Fuente, JC Cigudosa, AC Lloyd and A Bernad. (2005). Spontaneous human adult stem cell transformation. Cancer Res 65: 3035-3039.
28. Burns JS, BM Abdallah, P Guldberg, J Rygaard, HD Schroder and M Kassem. (2005). Tumorigenic heterogeneity in cancer stem cells evolved from long-term cultures of telomerase-immortalized human mesenchymal stem cells. Cancer Res 65:3126-3135.